Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Stress-induced Neuroinflammation of the Spinal Cord is Restrained by Cort113176 (Dazucorilant), A Specific Glucocorticoid Receptor Modulator.
Journal: Molecular neurobiology
Published: April 05, 2023
Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism.
Journal: AACE clinical case reports
Published: April 30, 2021
Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases.
Journal: International journal of molecular sciences
Published: February 28, 2020
Resetting the Stress System with a Mifepristone Challenge.
Journal: Cellular and molecular neurobiology
Published: July 15, 2018
The Selective Glucocorticoid Receptor Modulator Cort 113176 Reduces Neurodegeneration and Neuroinflammation in Wobbler Mice Spinal Cord.
Journal: Neuroscience
Published: February 16, 2018
Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.
Journal: Journal of clinical psychopharmacology
Published: July 15, 2017
Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response.
Journal: Biological psychiatry
Published: July 05, 2017
Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist.
Journal: Journal of medicinal chemistry
Published: April 04, 2017
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double-Blind, Randomized, Placebo-Controlled Phase 1 Clinical Study.
Journal: Clinical pharmacology in drug development
Published: March 01, 2017
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
Journal: Neurobiology of aging
Published: January 07, 2016
Last Updated: 09/26/2026